Company to wind down the GOBLET gastrointestinal study to focus on registration path in the U.S. With sufficient cash on hand to execute near-term milestones, the Company expects to avoid immediate material dilution SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced that it has concluded enrollment in the GOBLET study, having generated the necessary clinical and tr ...

Key Regulatory Milestones Support Expanded Commercial Activity and Provide Framework for Scale-UpVANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that the United States Environmental Protection Agency (“EPA”) has issued a TSCA Section 5(e) Order under Premanufacture Notice (PMN) numbers P-24-0086-87 for HydroGraph’s graphene materials described as graphene, turbostratic, 3-9 layers (P-24-0086) ...

Florida-Born Wing Brand Brings Signature Wings to Greater Houston Area LOS ANGELES, Feb. 24, 2026 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc., parent company of Hurricane Grill & Wings and 17 other restaurant concepts, announces the opening of the first Hurricane Grill & Wings in the greater Houston area, and the second location for the beloved wing brand in Texas. Located in the Plantation Village shopping center, the new Lake Jackson restaurant offers guests a welcoming dining experienc ...

MONTRÉAL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Air Canada was named one of Canada's Best Diversity Employers for 2026, the eighth time in a decade the airline has received this recognition. "We’re proud to be recognized for our ongoing commitment to diversity, equity and inclusion. This award spotlights how our employees, resource groups, champions, leaders, and community partners work together to build a more fair, equitable, and inclusive future where everyone feels they belong," said Arielle Meloul-Wechsle ...

Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular dystrophyHOPE-3 clinical study report (CSR) submitted to the U.S. Food and Drug Administration (FDA) in support of the ongoing BLA review SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that results from its Phase 3 HOPE-3 clini ...

New virtual agent capabilities reduce customer effort, prevent repeat contacts, and give service leaders confidence to scale automationWith 43% of consumers saying chatbots fail to resolve their issues, Zoom Virtual Agent 3.0 can help organizations close that gap SAN JOSE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Today Zoom Communications, Inc. (NASDAQ: ZM) unveiled Zoom Virtual Agent 3.0 (ZVA), the next evolution in agentic automation. ZVA introduces a new execution architecture and expanded AI capabiliti ...

A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced its award-winning photographers, editors and operations staff will capture stunning imagery from the Milano Cortina 2026 Paralympic Winter Games. As the Official Photographic Agency of the International Paralympic Committee (IPC), Getty Images will deploy a team of 30 photograp ...

MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expanding its base of subscri ...

Initial 13-site deployment with UK subsidiary of global construction firm employing 35,600 employees across 50+ countries, validates commercial scalability and ROI of INBS’s fingerprint drug testing technologyNEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a partnership with Bouygues UK, a subsidiary of Bouygues Construction, a multi ...

Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysis FDA Fast Track designation offers clear pathway for ateganosine as third-line therapy for non-small cell lung cancer (NSCLC) First and only direct telomere-targeting anticancer agent in clinical development anywhere MAIA CEO details development pipeline in letter to shareholders CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, ...